Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126254612 | 12625461 | 2 | F | 20160502 | 20160804 | 20160805 | 20160811 | EXP | US-PFIZER INC-2016374563 | PFIZER | 53.00 | YR | F | Y | 150.00000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126254612 | 12625461 | 1 | PS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | 25 MG, 1X/DAY | Y | SASA15004-A | 19839 | 25 | MG | FILM-COATED TABLET | QD | |||||
| 126254612 | 12625461 | 2 | SS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Y | 19839 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126254612 | 12625461 | 1 | Depression |
| 126254612 | 12625461 | 2 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126254612 | 12625461 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126254612 | 12625461 | Dizziness | |
| 126254612 | 12625461 | Nausea | |
| 126254612 | 12625461 | Postmenopausal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126254612 | 12625461 | 1 | 20160501 | 201606 | 0 |